May, 21 2020

Amanat Appoints Dr. Mohamad Hamade as CEO

21 May 2020 | Dubai | Amanat Holdings PJSC (“Amanat” or the “Company”), the GCC’s largest healthcare and education investment company, today announced the appointment of Dr. Mohamad Hamade as Chief Executive Officer (“CEO”) of the company.

Dr. Hamade, previously the Chief Investment Officer (“CIO”) of Amanat Holdings, succeeds Mr. Tristan de Boysson who held the position as the CEO of Amanat since February 2019 and led the company during a period of integration and optimization of Amanat’s newly acquired portfolio companies.

Dr. Hamade, during his position as CIO, was instrumental in driving Amanat’s portfolio growth since his joining in November 2017, having led a series of successful acquisitions in 2018 amounting to AED 1.2 billion and contributing to the company’s 40% growth in profitability in FY 2019. As a member of the boards and executive committees of Amanat’s investee companies, Dr. Hamade also plays a key role in driving growth and value creation across Amanat’s portfolio through various corporate strategy, corporate governance and corporate finance initiatives.

Dr. Mohamad has a wealth of experience in the healthcare and education sectors across the region and holds an M.D. and a BSc in Biology from the American University of Beirut, and an MBA from Cornell University in the USA. He also holds a Research Fellowship Certificate in ENT Surgery from Harvard Medical School.

Commenting on behalf of the Board, Mr. Hamad Abdulla Al Shamsi, Chairman of Amanat, said: “We have the utmost faith in Dr. Hamade’s leadership and strategic capabilities, which he has demonstrated continuously during his role as CIO and we are confident that he will succeed in delivering Amanat’s future growth prospects. We also look forward to supporting Dr. Hamade in the delivery of our strategic objectives and overseeing Amanat’s growth plans in the coming phase. I would also like to take the opportunity to thank Tristan for his leadership over the course of his tenure and wish him the best in his future endeavors.”

Dr. Mohamad Hamade commented: “I am delighted and proud to serve as Amanat’s chief executive officer at such a crucial stage in its investment cycle. The journey ahead in Amanat is an exciting one as we continue to build on our track record as a leading investment company in healthcare and education in the region. Despite the macro-economic challenges, I believe this is the time for us to optimize our operations, grasp opportunities, and play a key role as a market consolidator which will enable us to build and grow our existing platforms and enhance shareholder returns.

- End –

About Amanat Holdings PJSC
Amanat Holdings PJSC is the region’s largest integrated healthcare and education investment company with paid-up capital of AED2.5 billion. Listed on the Dubai Financial Market (DFM) since 2014, Amanat has a mandate to establish, acquire and incorporate companies working in the healthcare and education sectors, and develop, manage and operate these companies within the GCC and beyond. Amanat’s healthcare platform includes International Medical Center (IMC), a 300-bed multi-disciplinary hospital based in Jeddah, Saudi Arabia; Sukoon, a provider of acute extended care, critical care and home care medical services in Jeddah, Saudi Arabia; and the Royal Hospital for Women and Children (RHWC), a world-class hospital for women and children located in the Kingdom of Bahrain. Amanat’s education platform includes Taaleem, a leading provider of K12 and early education in the UAE; Abu Dhabi University Holding Company, a leading provider of higher education; and Middlesex University Dubai, the first overseas campus of the internationally renowned Middlesex University in London. Amanat also owns the real estate assets of the North London Collegiate School in Dubai, UAE.

Investor Relations Contact
Sara Shadid
Head of Investor Relations
+971 (0) 4 330 9999
investor.relations@amanat.com

For further information visit: www.amanat.com

For Media EnquiriesPlease Contact

media@amanat.com +971 4 450 7600

LATEST FROM AMANAT